Evidence mapPaperPMID 42110412Full record

ArticleFrontiers in medicine2026

Factors associated with an unfavorable outcome according to age in patients with COVID-19 admitted to intensive care in mainland France during the first three periods of the pandemic: a nationwide cohort study.

Antoine Journé, Sabrina Tessier, Anna Maisa, Cécile Durand, Delphine Viriot, Isabelle Parent du Châtelet, Olivier Retel, Jean-Pierre Quenot, Christine Binquet

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Antoine JournéUniversité Bourgogne Europe, CHU Dijon Bourgogne, Centre d'Investigation Clinique, Module épidémiologie clinique, INSERM, CIC1432, Dijon, France.
Sabrina TessierSanté publique France (French National Public Health Agency), Saint-Maurice, France.
Anna MaisaSanté publique France (French National Public Health Agency), Saint-Maurice, France.
Cécile DurandSanté publique France (French National Public Health Agency), Saint-Maurice, France.
Delphine ViriotSanté publique France (French National Public Health Agency), Saint-Maurice, France.
Isabelle Parent du ChâteletSanté publique France (French National Public Health Agency), Saint-Maurice, France.
Olivier RetelSanté publique France (French National Public Health Agency), Saint-Maurice, France.
Jean-Pierre QuenotUniversité Bourgogne Europe, CHU Dijon Bourgogne, Centre d'Investigation Clinique, Module épidémiologie clinique, INSERM, CIC1432, Dijon, France.
Christine BinquetUniversité Bourgogne Europe, CHU Dijon Bourgogne, Centre d'Investigation Clinique, Module épidémiologie clinique, INSERM, CIC1432, Dijon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Coronavirus disease 2019 (COVID-19) can affect multiple organs, especially the lungs, which may lead to intensive care unit (ICU) admission in the case of acute respiratory distress syndrome (ARDS). Other unfavorable outcomes can occur such as need for orotracheal intubation (OTI) and/or extracorporeal membrane oxygenation (ECMO) and even death. We took advantage of national surveillance data from ICU admissions managed by Santé publique France to investigate the factors associated with mortality, severe ARDS, ICU-free days as well as need for invasive ventilatory support in mainland France between February 2020 and June 2021. Methods: This nationwide cohort study analyzed critically ill COVID-19 patients admitted to ICU. We used Fine and Gray's model and linear and logistic regressions to assess the factors associated with different outcomes. The main variable of interest was the first three periods of the pandemic: period 1 (February to July 2020), period 2 (August to December 2020) and period 3 (January to June 2021). We stratified all analyses according to predefined age groups: <45, 45-64 and ≥65 years. Results: The 15,423 included patients were mainly men (70%). Mean age was 64.1 ± 13.0 years. Mortality remained high throughout all three pandemic periods. The third pandemic period was associated with a higher risk of severe ARDS in patients aged ≥65 years as well as more ICU-free days and less use of invasive respiratory support regardless of age. Obesity was associated with a lower risk of death in patients aged ≥45 and a higher risk of severe ARDS and requiring invasive respiratory support in patients aged ≥65. Male sex was associated with a higher risk of death regardless of age, a higher risk of severe ARDS in patients aged ≥45 as well as fewer ICU-free days and a higher risk of using invasive respiratory support in patients aged ≥65. Conclusion: Prognosis did not significantly improve over time for COVID-19 patients admitted to ICU, however our findings highlight obesity and male sex as key factors in most severe COVID-19 cases, particularly in the elderly. This study also showed a reduction in the use of invasive respiratory support, irrespective of patient severity.

Indexed as

acute respiratory distress syndromeCOVID-19Franceintensive care unitinvasive respiratory supportmortality

Identifiers

PMID42110412
PMCPMC13149367

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.